B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price target from $17 to $16.
B of A Securities Maintains Underperform on Core Laboratories, Lowers Price Target to $16
Company Profile